PRES: posterior or potentially reversible encephalopathy syndrome?
Posterior reversible encephalopathy syndrome (PRES) is an acronym that identifies a new clinico-neuroradiologic entity occurring in association with different conditions. We report a patient with eclamptic encephalopathy whose clinico-radiological picture normalised after prompt treatment. We suggest defining this condition as potentially RES, to emphasise that reversibility is not spontaneous but is usually related to an adequate treatment, and that the posterior localisation of the lesions, even if constant, may not represent the most relevant finding in some patients.
Narbone
M C
MC
Dipartimento di Neuroscienze, U.O.C. Clinica Neurologica, A.O.U. G. Martino, Via C. Valeria-Contesse, I-98124, Messina, Italy. mcnarbone@yahoo.it
Musolino
R
R
Granata
F
F
Mazzù
I
I
Abbate
M
M
Ferlazzo
E
E
D000328:Adult; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001921:Brain / Q000473:pathology*; D001927:Brain Diseases / Q000145:classification* / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D003000:Clonidine / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D004461:Eclampsia / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008353:Mannitol; D009543:Nifedipine / Q000627:therapeutic use; D011247:Pregnancy; D012640:Seizures / Q000209:etiology
D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D004234:Diuretics, Osmotic; D008353:Mannitol; D008278:Magnesium Sulfate; D003907:Dexamethasone; D009543:Nifedipine; D003000:Clonidine; D003975:Diazepam